drugset / Trial / NCT05620940

A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.

NCT05620940

Phase 1 Recruiting 40 enrolled Inventage Lab., Inc.
Non-randomizedSequentialOpen-labelTreatment

Summary

A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.

Timeline

Start
2024-09-11
Primary completion
2025-12-30
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject IVL3004 Unknown Intramuscular
Subject IVL4002 Unknown Subcutaneous
Comparator Naltrexone Small molecule Intramuscular